Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Theralase Technologies Inc
(OP:
TLTFF
)
0.1850
UNCHANGED
Streaming Delayed Price
Updated: 3:20 PM EDT, Apr 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.1850
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.1850
Today's Range
0.1850 - 0.1850
52wk Range
0.1019 - 0.2594
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Theralase(R) Closes $CAN 2.66 Million Financing
Today 7:00 EDT
Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage...
Via
Newsfile
Theralase(R) Discovers Further Mechanism on How Ruvidar(R) Inactivates Herpes Simplex Virus
March 17, 2026
Toronto, Ontario--(Newsfile Corp. - March 17, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage...
Via
Newsfile
Performance
YTD
+40.2%
+40.2%
1 Month
-8.2%
-8.2%
3 Month
+33.0%
+33.0%
6 Month
+29.4%
+29.4%
1 Year
+31.9%
+31.9%
More News
Read More
Theralase(R) Closes $1.1 M Non-Brokered Private Placement
March 10, 2026
Via
Newsfile
Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer
March 09, 2026
Via
Newsfile
Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
February 20, 2026
Via
Newsfile
Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
↗
February 17, 2026
Via
Newsfile
Theralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting
February 10, 2026
Via
Newsfile
Theralase(R) Provides Update on Bladder Cancer Clinical Study
February 04, 2026
Via
Newsfile
Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study
February 02, 2026
Via
Newsfile
Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
January 12, 2026
Via
Newsfile
Theralase(R) Closes $1.3 M Non-Brokered Private Placement
December 23, 2025
Via
Newsfile
Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
December 12, 2025
Via
Newsfile
Theralase(R) Investor Conference Call Reminder
November 17, 2025
Via
Newsfile
Theralase(R) Releases 3Q2025 Financial Statements
November 10, 2025
Via
Newsfile
Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug
November 03, 2025
Via
Newsfile
Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus
September 24, 2025
Via
Newsfile
Topics
Derivatives
Theralase(R) Extends Warrants
August 29, 2025
Via
Newsfile
Theralase(R) Releases 2Q2025 Financial Statements
August 26, 2025
Via
Newsfile
Theralase(R) Closes Non-Brokered Private Placement
July 28, 2025
Via
Newsfile
Theralase(R) Extends Warrants
June 27, 2025
Via
Newsfile
Theralase(R) Closes Non-Brokered Private Placement
June 17, 2025
Via
Newsfile
Theralase Completes Annual General and Special Meeting
June 12, 2025
Via
Newsfile
Theralase Annual General Meeting
June 05, 2025
Via
Newsfile
Theralase(R) 1Q2025 Financial Statements
May 30, 2025
Via
Newsfile
CORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025
May 29, 2025
Via
Newsfile
Frequently Asked Questions
Is Theralase Technologies Inc publicly traded?
Yes, Theralase Technologies Inc is publicly traded.
What exchange does Theralase Technologies Inc trade on?
Theralase Technologies Inc trades on the OTC Traded
What is the ticker symbol for Theralase Technologies Inc?
The ticker symbol for Theralase Technologies Inc is TLTFF on the OTC Traded
What is the current price of Theralase Technologies Inc?
The current price of Theralase Technologies Inc is 0.1850
When was Theralase Technologies Inc last traded?
The last trade of Theralase Technologies Inc was at 04/09/26 03:20 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.